Literature DB >> 9069852

Placebo orthodoxy in clinical research. II: Ethical, legal, and regulatory myths.

B Freedman, K C Glass, C Weijer.   

Abstract

Keywords:  Analytical Approach; Biomedical and Behavioral Research; Declaration of Helsinki; Legal Approach

Mesh：

Substances：

Year:  1996        PMID： 9069852     DOI： 10.1111/j.1748-720x.1996.tb01860.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN： 1073-1105            Impact factor:   1.718


× No keyword cloud information.
  13 in total

1.  Declaration of Helsinki should be strengthened.

Authors:  K J Rothman
Journal:  BMJ       Date:  2000-08-12

2.  Surgical "placebo" controls.

Authors:  Robert Tenery; Herbert Rakatansky; Frank A Riddick; Michael S Goldrich; Leonard J Morse; John M O'Bannon; Priscilla Ray; Sherie Smalley; Matthew Weiss; Audiey Kao; Karine Morin; Andrew Maixner; Sam Seiden
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

Review 3.  Benefits and burdens of placebos in psychiatric research.

Authors:  Scott Y H Kim
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

4.  The ethics of placebo in clinical psychopharmacology: the urgent need for consistent regulation.

Authors:  Simon N Young; Lawrence Annable
Journal:  J Psychiatry Neurosci       Date:  2002-09       Impact factor: 6.186

Review 5.  Using empirical data to inform the ethical evaluation of placebo controlled trials.

Authors:  Jeremy Sugarman
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

6.  The relevance of empirical research in bioethics.

Authors:  Franklin G Miller; David Wendler
Journal:  Schizophr Bull       Date:  2005-09-28       Impact factor: 9.306

Review 7.  The ethics of drug research in children.

Authors:  T F Ackerman
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

8.  Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.

Authors:  Allison C Nugent; Nicolas D Iadarola; Frank G Miller; David A Luckenbaugh; Carlos A Zarate
Journal:  Lancet Psychiatry       Date:  2016-03-10       Impact factor: 27.083

9.  A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders.

Authors:  B W Dunlop; J Banja
Journal:  J Med Ethics       Date:  2009-06       Impact factor: 2.903

10.  Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.